Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,161 to 1,180 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R01AG050431 | Characterizing novel hippocampal drugs for Alzheimer's disease | 1 | 2020 |
| R01AG051729 | Cellular senescence as a mediator of mitochondrial dysfunction-induced aging | 1 | 2020 |
| R01AG051807 | Exercise-induced epigenetic mechanisms underlying neuronal plasticity and cognition | 1 | 2020 |
| R01AI073898 | Virus Host Interactions that Regulate Translation in Cells Infected with HSV-1 | 1 | 2020 |
| R01AI084880 | In vivo behavior of monocytes in resting and inflammatory conditions | 1 | 2020 |
| R01AI107022 | Innate Effectors and Type-2 Inflammation | 1 | 2020 |
| R01AI116577 | Granzyme and Granulysin Mediated Death of Trypanosoma cruzi | 1 | 2020 |
| R01AI116885 | Regulation of TH17 Cell Development and Function by the REV-ERBs | 1 | 2020 |
| R01AI121405 | Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity | 1 | 2020 |
| R01AI121567 | Immune Dysregulation During Multiple Sclerosis Relapse | 1 | 2020 |
| R01AI123126 | Integrin-dependent modulation of macrophage function | 1 | 2020 |
| R01AI123155 | The biology of the nuclear export protein in influenza A virus replication | 1 | 2020 |
| R01AI124121 | Restoring macrophage function in cystic fibrosis | 1 | 2020 |
| R01AI124965 | The Lymphoid Tissue Pharmacology of Antiretroviral Drugs | 1 | 2020 |
| R01AI128779 | Penile Microbiome, Inflammation and HIV Susceptibility During Sexual Debut and Maturation Among Male Adolescents | 1 | 2020 |
| R01AI128799 | Understanding Rectal HIV transmission among At-risk MSM: Age, Intercourse, and Mucosal Injur | 1 | 2020 |
| R01AR070865 | Targeting DNA Demethylation Regulators in Osteoarthritis | 1 | 2020 |
| R01CA049152 | Signal Transduction by Non-Transmembrane PTPs | 1 | 2020 |
| R01CA076445 | Studies of HHV-8 vIL-6 Function | 1 | 2020 |
| R01CA136494 | Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=59